uk 68798 has been researched along with ivabradine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duff, HJ; Gerull, B; Guo, J; Kudaibergenova, M; Lees-Miller, J; Muruve, DA; Noskov, SY; Ol'khovich, M; Perissinotti, L; Perlovich, GL; Sharapova, A | 1 |
| Gabrielsson, J; Jirstrand, M; Martel, E; Pairet, N; Scheuerer, S; Wallman, M | 1 |
2 other study(ies) available for uk 68798 and ivabradine
| Article | Year |
|---|---|
The Pore-Lipid Interface: Role of Amino-Acid Determinants of Lipophilic Access by Ivabradine to the hERG1 Pore Domain.
Topics: Binding Sites; Ether-A-Go-Go Potassium Channels; Humans; Ivabradine; Membrane Lipids; Models, Molecular; Molecular Docking Simulation; Molecular Dynamics Simulation; Mutagenesis, Site-Directed; Phenethylamines; Protein Binding; Protein Structure, Tertiary; Sulfonamides | 2019 |
An Integrative Approach for Improved Assessment of Cardiovascular Safety Data.
Topics: Animals; Biomarkers, Pharmacological; Blood Pressure; Cardiotoxicity; Cardiovascular Agents; Heart Rate; Ivabradine; Male; Phenethylamines; Pyridazines; Rats; Rats, Wistar; Sildenafil Citrate; Sulfonamides | 2021 |